INTERNATIONAL JOURNAL OF ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2023-02-17 yzhdx 来自广西

一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了

47 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2023-06-13 ms3000001934409486 来自安徽省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：前列腺癌
经验分享：开帖分享一下：6月10 submitted

88 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2023-05-02 ms8000000835713473

请问这个期刊收case吗

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2023-01-09 ms3000000631272663 来自德国

最近有人投稿吗？分享下投稿进度？已经十天了还是submitted

43 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2022-06-12 ms7000000459330790

偏重的研究方向：肿瘤
经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了

54 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2022-11-01 a3103338

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：生信
经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2023-01-13 ms3000001851119746 来自河北省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：经验分享：2022年9.28提交
10.27 外审修回，3个审稿人修了4次
2023.1.13接收

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2022-12-30 ms7000000631832992 来自山东省

一般多久能进外审啊，已经一个多周了还在submitted

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2021-04-01 zzx

请问需要提供原始数据吗？

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115054, encodeId=106f211505410, content=一个多月了，还是Under review,这到底是内审还是外审啊？有人传授一下经验吗，都准备答辩了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Fri Feb 17 10:13:33 CST 2023, time=2023-02-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2142615, encodeId=201b21426150e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌 经验分享：开帖分享一下：6月10 submitted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230724/f6ff49274b4c450bb5ce22714896fd31/ef43ceb74c4f403797e71c4c086060e6.jpg, createdBy=33518647109, createdName=ms3000001934409486, createdTime=Tue Jun 13 21:28:50 CST 2023, time=2023-06-13, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2129705, encodeId=16de2129e05f9, content=请问这个期刊收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220204/30b604e1a9314662beb67210c93f6c93/318dae3e7bee43b19bd1a3b14cfd17b5.jpg, createdBy=cb946490341, createdName=ms8000000835713473, createdTime=Tue May 02 14:17:38 CST 2023, time=2023-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109529, encodeId=d4fe210952911, content=最近有人投稿吗？分享下投稿进度？已经十天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Mon Jan 09 16:56:27 CST 2023, time=2023-01-09, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=1226017, encodeId=1fc6122601e41, content=偏重的研究方向：肿瘤 经验分享：这个杂志速度也太慢了吧，6月1号投的，2号改了格式返回去，一直到现在还是submitted，是还没送到编辑那吗??还是说外审找不到人啊，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3fc8122473, createdName=ms7000000459330790, createdTime=Sun Jun 12 18:16:37 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097894, encodeId=ae9a209e89466, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：不是说生信友好么，怎么搜这家期刊全都是基础实验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=436c5529222, createdName=a3103338, createdTime=Tue Nov 01 17:54:14 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110027, encodeId=33bb211002ee3, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：经验分享：2022年9.28提交 10.27 外审修回，3个审稿人修了4次 2023.1.13接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b45616068, createdName=ms3000001851119746, createdTime=Fri Jan 13 08:27:29 CST 2023, time=2023-01-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108195, encodeId=ab93210819534, content=一般多久能进外审啊，已经一个多周了还在submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61555705088, createdName=ms7000000631832992, createdTime=Fri Dec 30 21:03:01 CST 2022, time=2022-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=952993, encodeId=ff64952993b5, content=请问需要提供原始数据吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6305475674, createdName=zzx, createdTime=Thu Apr 01 08:40:14 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102529, encodeId=517a21025297e, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝癌 经验分享：希望审核能快速一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230403/009ff585e1a741dea7bf132b2ffef5e0/6105ae33389c44ab9afa81630c167c62.jpg, createdBy=e23a8328293, createdName=ms3000002029349918, createdTime=Fri Nov 25 01:04:38 CST 2022, time=2022-11-25, status=1, ipAttribution=辽宁省)]

2022-11-25 ms3000002029349918 来自辽宁省

审稿速度:4.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;肝癌
经验分享：希望审核能快速一些

45 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务